164 related articles for article (PubMed ID: 33887508)
1. Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction: A new proposal for the pathophysiology of preeclampsia.
Matsuyama T; Tomimatsu T; Mimura K; Yagi K; Kawanishi Y; Kakigano A; Nakamura H; Endo M; Kimura T
J Reprod Immunol; 2021 Jun; 145():103322. PubMed ID: 33887508
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.
Guseh SH; Feinberg BB; Dawood HY; Yamamoto HS; Fichorova RN; Burwick RM
Am J Reprod Immunol; 2015 May; 73(5):437-44. PubMed ID: 25521546
[TBL] [Abstract][Full Text] [Related]
3. Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells.
Banadakoppa M; Balakrishnan M; Yallampalli C
Am J Reprod Immunol; 2018 Nov; 80(5):e13033. PubMed ID: 30099798
[TBL] [Abstract][Full Text] [Related]
4. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
[TBL] [Abstract][Full Text] [Related]
5. InĀ vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
6. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
7. Drug Repositioning for Preeclampsia Therapeutics by In Vitro Screening: Phosphodiesterase-5 Inhibitor Vardenafil Restores Endothelial Dysfunction via Induction of Placental Growth Factor.
Kakigano A; Tomimatsu T; Mimura K; Kanayama T; Fujita S; Minato K; Kumasawa K; Taniguchi Y; Kanagawa T; Endo M; Ishihara T; Namba T; Mizushima T; Kimura T
Reprod Sci; 2015 Oct; 22(10):1272-80. PubMed ID: 25736325
[TBL] [Abstract][Full Text] [Related]
8. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.
Yonekura Collier AR; Zsengeller Z; Pernicone E; Salahuddin S; Khankin EV; Karumanchi SA
Hypertens Pregnancy; 2019 Aug; 38(3):193-199. PubMed ID: 31291799
[TBL] [Abstract][Full Text] [Related]
9. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
10. Placental growth factor is negatively regulated by epidermal growth factor receptor (EGFR) signaling.
Whigham CA; Hastie R; Hannan NJ; Brownfoot F; Pritchard N; Cannon P; Nguyen TV; Kandel M; Masci J; Tong S; Kaitu'u-Lino TJ
Placenta; 2021 Oct; 114():22-28. PubMed ID: 34418751
[TBL] [Abstract][Full Text] [Related]
11. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction.
Brownfoot FC; Hannan NJ; Cannon P; Nguyen V; Hastie R; Parry LJ; Senadheera S; Tuohey L; Tong S; Kaitu'u-Lino TJ
EBioMedicine; 2019 Mar; 41():636-648. PubMed ID: 30824385
[TBL] [Abstract][Full Text] [Related]
12. Biomarker Immunoassays in the Diagnosis of Preeclampsia: Calculating the sFlt1/PlGF Ratio Using the Cobas
Black C; da Silva Costa F
Methods Mol Biol; 2018; 1710():9-26. PubMed ID: 29196991
[TBL] [Abstract][Full Text] [Related]
13. The Potential for Placental Activation of PPARĪ³ to Improve the Angiogenic Profile in Preeclampsia.
Grimaldi B; Kohan-Ghadr HR; Drewlo S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359910
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
[TBL] [Abstract][Full Text] [Related]
15. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
[TBL] [Abstract][Full Text] [Related]
16. Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library.
Yagi K; Mimura K; Tomimatsu T; Matsuyama T; Kawanishi Y; Kakigano A; Nakamura H; Endo M; Kimura T
PLoS One; 2020; 15(12):e0244684. PubMed ID: 33378412
[TBL] [Abstract][Full Text] [Related]
17. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
18. Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study.
Zhang Y; Huang Q; Tang M; Zhang J; Fan W
PLoS One; 2015; 10(6):e0129945. PubMed ID: 26091360
[TBL] [Abstract][Full Text] [Related]
19. Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus.
Nuzzo AM; Giuffrida D; Moretti L; Re P; Grassi G; Menato G; Rolfo A
Sci Rep; 2021 Jan; 11(1):2312. PubMed ID: 33504861
[TBL] [Abstract][Full Text] [Related]
20. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
